Sweet's syndrome and neutrophilic panniculitis associated with G-CSF treatment in a patient with myelodysplasia

Sweet's syndrome and neutrophilic panniculitis associated with G-CSF treatment in a patient with myelodysplasia

Bibliographic Details
Main Authors:	Brown, V, Vyas, P, Hollowood, K, Burge, S, Wordsworth, P, Cooper, S
Format:	Conference item
Published:	2008

Similar Items

Subcutaneous panniculitis-like T-cell lymphoma.
by: Rolinski, M, et al.
Published: (2010)

Pustular panniculitis in rheumatoid arthritis.
by: Anstey, A, et al.
Published: (1991)

Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.
by: Boultwood, J, et al.
Published: (1991)

Pathophysiology and treatment of myelodysplasia with del(5q)
by: Bello, E
Published: (2017)

Chromosomal deletions in myelodysplasia.
by: Boultwood, J, et al.
Published: (1995)

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
by: Bystrom, J, et al.
Published: (2017)

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
by: Pellagatti, A, et al.
Published: (2018)

Unusual association of diseases/symptoms: Sweet's syndrome in Crohn's colitis
by: Abdullah , Sheikh Anwar, et al.
Published: (2009)

Glutathione S-transferase gene deletions in myelodysplasia.
by: Atoyebi, W, et al.
Published: (1997)

Ha-ras hypervariable alleles in myelodysplasia.
by: Thein, S, et al.
Published: (1986)

The role of EZH2 in paediatric myelodysplasia
by: Fordham, N
Published: (2021)

Gene expression and risk of leukemic transformation in myelodysplasia
by: Shiozawa, Y, et al.
Published: (2017)

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
by: Nikpour, M, et al.
Published: (2007)

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
by: Papaemmanuil, E, et al.
Published: (2011)

Persistent malignant stem cells in del(5q) myelodysplasia in remission.
by: Tehranchi, R, et al.
Published: (2010)

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the a thalassaemia myelodysplasia syndrome (ATMDS)
by: Gibbons, R, et al.
Published: (2003)

Identification of acquired somatic mutations in the chromatin remodelling factor ATRX in the alpha thalassemia myelodysplasia syndrome (ATMDS).
by: Gibbons, R, et al.
Published: (2003)

INDUCTION OF A CDS+ T CELL RESPONSE TO THE MAGE CANCER TESTIS ANTIGEN BY COMBINED TREATMENT WITH AZACITIDINE AND SODIUM VALPROATE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASIA
by: Goodyear, O, et al.
Published: (2010)

Draft Genome Sequence of a Mycobacterium porcinum Strain Isolated from a Pet Cat with Atypical Mycobacterial Panniculitis
by: Mannion, Anthony, et al.
Published: (2020)

Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities.
by: Dennis, M, et al.
Published: (2013)

Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
by: Gibbons, R, et al.
Published: (2003)

Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.
by: Goodyear, O, et al.
Published: (2010)

ISOLATION OF YACS FOR CSF-1R AND CSF-1 AND GENE LOCALIZATION USING FISH
by: Boultwood, J, et al.
Published: (1992)

Origins of tumor-associated macrophages and neutrophils
by: Cortez-Retamozo, Virna, et al.
Published: (2014)

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia.
by: Pedersen-Bjergaard, J, et al.
Published: (2002)

Molecular insights into Down syndrome-associated leukemia.
by: Vyas, P, et al.
Published: (2007)

Analysis of factors affecting outcome in recipients of bone marrow transplantation for myelodysplasia; a single centre's experience over a nine year period
by: Stoll, V, et al.
Published: (2010)

Variation in immunoglobulin G and albumin concentrations during lumbar CSF removal: a reappraisal.
by: Rice, G, et al.
Published: (1982)

Comparison of polyacrylamide and agarose support media for detection of oligoclonal IgG bands in CSF.
by: North, J, et al.
Published: (1987)

Oligonucleotide microarray analysis of CD34+cells in patients with low risk myelodysplasia and age-matched healthy subjects.
by: Sternberg, A, et al.
Published: (2003)

FACTORS DETERMINING CLINICAL RESPONSE TO 5 '-AZACITDINE AND SODIUM VALPROATE COMBINATION THERAPY IN PATIENTS WITH HIGH RISK ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASIA
by: Craddock, C, et al.
Published: (2010)

Prognostic value of CSF lactate in cerebral malaria.
by: White, N, et al.
Published: (1987)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
by: Nikpour, M, et al.
Published: (2009)

Smap1 deficiency perturbs receptor trafficking and predisposes mice to myelodysplasia
by: Kon, S., et al.
Published: (2013)

CSF ELECTROPHORESIS IN 1000 PATIENTS
by: Ebers, G
Published: (1980)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
by: Craddock, C, et al.
Published: (2013)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia.
by: Craddock, C, et al.
Published: (2013)

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders
by: Gu, Y, et al.
Published: (2015)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
by: Papadopoulos, M, et al.
Published: (2011)

Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders (Protocol)
by: Gu, Y, et al.
Published: (2015)